Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.
Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions.
Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Antiviral Research - 15th International Conference. 17-21 March 2002, Prague, Czech Republic.
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma.
Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.